These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20799931)

  • 21. Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy.
    Moresco MN; Virgolino Hde A; de Morais MP; da Motta-Passos I; Gomes-Gouvêa MS; de Assis LM; Aguiar KR; Lombardi SC; Malheiro A; Cavalheiro Nde P; Levi JE; Torres KL
    Vox Sang; 2014 Jul; 107(1):19-25. PubMed ID: 24697276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA; Oyelese AO; Salawu L; Audu RA; Okwuraiwe AP; Aboderin AO
    Virol J; 2016 May; 13():76. PubMed ID: 27150469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC; St-Louis M; Perreault J; Caron B; Castilloux C; Laroche J; Delage G
    Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India.
    Panigrahi R; Majumder S; Gooptu M; Biswas A; Datta S; Chandra PK; Banerjee A; Chakrabarti S; Bandopadhyay D; De BK; Chakravarty R
    Ann Hepatol; 2012; 11(6):870-5. PubMed ID: 23109450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
    Fiedler SA; Oberle D; Chudy M; Scheiblauer H; Henseler O; Halbauer J; Heiden M; Funk M
    Vox Sang; 2019 Jul; 114(5):443-450. PubMed ID: 31012114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of hepatitis B virus infection in German blood donors 2008-2015.
    Scheiblauer H; Heiden M; Funk M; Oberle D; Kreß J; Jork C; Chudy M
    Vox Sang; 2020 Apr; 115(3):152-161. PubMed ID: 32023664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India.
    Banerjee A; Chandra PK; Datta S; Biswas A; Bhattacharya P; Chakraborty S; Chakrabarti S; Bhattacharya SK; Chakravarty R
    J Clin Virol; 2007 Dec; 40(4):312-7. PubMed ID: 17997353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
    Stolz M; Tinguely C; Fontana S; Niederhauser C
    Transfusion; 2014 Nov; 54(11):2961-7. PubMed ID: 24805974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples.
    Arora S; Doda V; Kirtania T
    Blood Transfus; 2015 Apr; 13(2):227-32. PubMed ID: 25369612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor.
    Datta S; Banerjee A; Chandra PK; Chakraborty S; Basu SK; Chakravarty R
    J Clin Virol; 2007 Nov; 40(3):255-8. PubMed ID: 17869170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers.
    Alzahrani FM; Muzaheed ; Shaikh SS; Alomar AI; Acharya S; Elhadi N
    Ann Lab Med; 2019 Jan; 39(1):81-85. PubMed ID: 30215234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination.
    Altunay H; Kosan E; Birinci I; Aksoy A; Kirali K; Saribas S; Aslan M; Yuksel P; Alan E; Yenen OS; Kocazeybek B
    Transfus Apher Sci; 2010 Dec; 43(3):265-268. PubMed ID: 20934912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil.
    Nishiya AS; Levi JE; de Almeida-Neto C; Witkin SS; Ferreira SC; Bassit L; Sabino EC; Di-Lorenzo-Oliveira C; Salles NA; Coutinho AS; Bellesa MA; Rocha V; Mendrone-Jr A
    Transfusion; 2021 May; 61(5):1495-1504. PubMed ID: 33687074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.